Enzetron-Solofarm, 100 mg/ml 10 ml 5 pcs

Citicoline is a natural endogenous compound that is an intermediate metabolite in the synthesis of phosphatidylcholine, one of the main structural components of the cell membrane.

Indications

– Acute period of ischemic stroke (as part of complex therapy).

– Recovery period of ischemic and hemorrhagic strokes.

– Traumatic brain injury, acute (as part of complex therapy) and recovery period.

– Cognitive and behavioral disorders in degenerative and vascular diseases of the brain.

Pharmacological effect

Citicoline is a natural endogenous compound that is an intermediate metabolite in the synthesis of phosphatidylcholine, one of the main structural components of the cell membrane.

Active ingredient

Citicoline

Composition

1 ml of the drug contains:

Active ingredient:

Citicoline sodium 104.5 mg

in terms of citicoline 100.0 mg

Excipients:

Liquid sorbitol (non-crystallizing) 200.0 mg

Glycerol anhydrous 50.0 mg

Sodium citrate dihydrate 6.0 mg

Anhydrous citric acid up to pH 5.0 – 7.0

Water for injections up to 1.0 ml.

Contraindications

– Hypersensitivity to any of the components of the drug.

– Should not be prescribed to patients with severe vagotonia (high tone of the parasympathetic part of the autonomic nervous system).

– Due to the lack of sufficient clinical data, it is not recommended for use in children under 18 years of age.

Side Effects

Side effects are grouped by frequency of occurrence: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1000 to < 1/100), rare (≥ 1/10000 to < 1/1000), very rare (< 1/10000), frequency not established.

Interaction

Citicoline enhances the effects of levodopa.

Overdose

Given the low toxicity of the drug, cases of overdose have not been described, even if therapeutic doses are exceeded.

Recommendations for use

Oral solution, applied orally.

Before use, the drug can be diluted in a small amount of water (100-120 ml or 1/2 cup). Take with meals or between meals.

Recommended dosage regimen

Acute period of ischemic stroke or traumatic brain injury (TBI): 1000 mg (10 ml) every 12 hours. Treatment duration is at least 6 weeks.

Recovery period of ischemic and hemorrhagic strokes, recovery period of TBI, cognitive and behavioral disorders in degenerative and vascular diseases of the brain: 500-2000 mg (5-20 ml) per day. The dosage and duration of treatment depend on the severity of the symptoms of the disease.

Elderly patients

When prescribing citicoline to elderly patients, no dose adjustment is required.

Functional features

Suction
Citicoline is well absorbed when taken orally. Absorption after oral administration is almost complete, and bioavailability is almost the same as after intravenous administration.

Storage conditions

At a temperature not exceeding 30 °C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiration date!

Manufacturer

Grotex LLC, Russia